Methyl 2-hydroxy-5-methoxy-3-nitrobenzoate
CAS: 2888-09-7
Ref. 3D-CAA88809
| 1g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
Methyl 2-hydroxy-5-methoxy-3-nitrobenzoate
Descrição:
Methyl 2-hydroxy-5-methoxy-3-nitrobenzoate (HMN) is a potent anticancer agent that has been shown to be cytotoxic in a variety of cancer cell lines. It inhibits the activity of topoisomerase II, leading to DNA damage and apoptosis. HMN also induces the release of cytochrome c from mitochondria, which activates caspases and initiates apoptosis. HMN has been studied for its cytotoxic effects on colorectal cancer cells. HMN was found to inhibit the growth of colorectal cancer cell lines with an IC50 value of 0.6 microM, but not normal colon cells. This suggests that HMN may be used as a chemotherapeutic agent against colorectal cancer.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
227.17 g/mol
Fórmula:
C9H9NO6
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
